Irina M Conboy

UC Berkeley and QB3 Institutes (USA)

Her research goup uncovers the behavior of organ stem cells in young versus aged tissues: muscle, brain, liver, skin, etc., with the goal to identify common age-imposed alterations that are responsible for pathological changes. The translational value of this research is in treating a number of age-associated degenerative and metabolic diseases as a class through engineered “youthful” modification of key molecular factors. We also work on restoring the mutated genes to their wild type sequences through CRSIPR nanoparticle delivery, which has broad applicability for treating a number of genetic diseases.